Sustained D-dimer Normalization and Reduced Incidence of Thrombosis Events in Pegcetacoplan-treated Patients with Paroxysmal Nocturnal Hemoglobinuria: Week 48 Interim Results From the 307 Long-term Extension Study (THSNA 2022) - Apellis Medical Hub

Sustained D-dimer Normalization and Reduced Incidence of Thrombosis Events in Pegcetacoplan-treated Patients with Paroxysmal Nocturnal Hemoglobinuria: Week 48 Interim Results From the 307 Long-term Extension Study

Share Via Email

Back to Conference Resources

PNH Congress Presentations Thrombosis and Hemostasis Societies of North America (THSNA) 2022

The following information is available for educational purposes only. The information is not to be re-purposed or re-used in its current form or presentation for any personal or professional use. Apellis reserves the right to withdraw, modify or change the information that is available on this website at any time.